Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Nuclear Medicine

  Free Subscription


Articles published in Semin Nucl Med

Retrieve available abstracts of 81 articles:
HTML format



Single Articles


    September 2022
  1. DE AZEVEDO D, Geers J, Gheysens O, Dweck M, et al
    (18)F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases.
    Semin Nucl Med. 2022 Sep 15. pii: S0001-2998(22)00075.
    PubMed     Abstract available


  2. TREGLIA G, Albano D, Dondi F, Bertagna F, et al
    A Role of [(18)F]FDG PET/CT for Response Assessment in Large Vessel Disease?
    Semin Nucl Med. 2022 Sep 5. pii: S0001-2998(22)00070.
    PubMed     Abstract available


  3. SAKELLIS CG, Jacene HA
    Imaging for Radiation Planning in Breast Cancer.
    Semin Nucl Med. 2022;52:542-550.
    PubMed     Abstract available


  4. ULANER GA
    16alpha-18F-fluoro-17beta-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer.
    Semin Nucl Med. 2022;52:574-583.
    PubMed     Abstract available


  5. HATAZAWA J
    The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update.
    Semin Nucl Med. 2022;52:619-627.
    PubMed     Abstract available


  6. COOK GJR
    Imaging of Bone Metastases in Breast Cancer.
    Semin Nucl Med. 2022;52:531-541.
    PubMed     Abstract available


    August 2022
  7. LOPCI E, Castello A, Mansi L
    FDG PET/CT for Staging and Restaging Malignant Mesothelioma.
    Semin Nucl Med. 2022 Aug 11. pii: S0001-2998(22)00068.
    PubMed     Abstract available


  8. ANKRAH AO, Lawal IO, Dierckx RAJO, Sathekge MM, et al
    Imaging of Invasive Fungal Infections- The Role of PET/CT.
    Semin Nucl Med. 2022 Aug 3. pii: S0001-2998(22)00057.
    PubMed     Abstract available


    July 2022
  9. DENDL K, Koerber SA, Tamburini K, Mori Y, et al
    Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.
    Semin Nucl Med. 2022 Jul 13. pii: S0001-2998(22)00033.
    PubMed     Abstract available


  10. DEJANOVIC D, Specht L, Czyzewska D, Kiil Berthelsen A, et al
    Response Evaluation Following Radiation Therapy With (18)F-FDG PET/CT: Common Variants of Radiation-Induced Changes and Potential Pitfalls.
    Semin Nucl Med. 2022 Jul 11. pii: S0001-2998(22)00055.
    PubMed     Abstract available


  11. BRINK A
    Pitfalls of Radionuclide Renal Imaging in Pediatrics.
    Semin Nucl Med. 2022;52:432-444.
    PubMed     Abstract available


  12. VOLKAN-SALANCI B, Erbas B
    Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting.
    Semin Nucl Med. 2022;52:445-452.
    PubMed     Abstract available


  13. BAR-SEVER Z, Shammas A, Gheisari F, Vali R, et al
    Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy.
    Semin Nucl Med. 2022;52:419-431.
    PubMed     Abstract available


    June 2022
  14. MANAPOV F, Eze C, Holzgreve A, Kasmann L, et al
    PET/CT for Target Delineation of Lung Cancer Before Radiation Therapy.
    Semin Nucl Med. 2022 Jun 30. pii: S0001-2998(22)00053.
    PubMed     Abstract available


  15. KRARUP MMK, Fischer BM, Christensen TN
    New PET Tracers: Current Knowledge and Perspectives in Lung Cancer.
    Semin Nucl Med. 2022 Jun 22. pii: S0001-2998(22)00052.
    PubMed     Abstract available


  16. KANDATHIL A, Subramaniam RM
    FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
    Semin Nucl Med. 2022 Jun 20. pii: S0001-2998(22)00048.
    PubMed     Abstract available


  17. MANAFI-FARID R, Askari E, Shiri I, Pirich C, et al
    [(18)F]FDG-PET/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications.
    Semin Nucl Med. 2022 Jun 15. pii: S0001-2998(22)00035.
    PubMed     Abstract available


    May 2022
  18. MARCUS C, Tajmir SH, Rowe SP, Sheikhbahaei S, et al
    (18)F-FDG PET/CT for Response Assessment in Lung Cancer.
    Semin Nucl Med. 2022 May 28. pii: S0001-2998(22)00032.
    PubMed     Abstract available


  19. LEGER MA, Routy B, Juneau D
    FDG PET/CT for Evaluation of Immunotherapy Response in Lung Cancer Patients.
    Semin Nucl Med. 2022 May 27. pii: S0001-2998(22)00047.
    PubMed     Abstract available


  20. GROHEUX D
    FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer.
    Semin Nucl Med. 2022 May 27. pii: S0001-2998(22)00051.
    PubMed     Abstract available


  21. GROOTJANS W, Rietbergen DD, van Velden FH
    Added Value of Respiratory Gating in Positron Emission Tomography for the Clinical Management of Lung Cancer Patients.
    Semin Nucl Med. 2022 May 25. pii: S0001-2998(22)00037.
    PubMed     Abstract available


  22. SANDACH P, Seifert R, Fendler WP, Hautzel H, et al
    A Role for PET/CT in response assessment of malignant pleural mesothelioma.
    Semin Nucl Med. 2022 May 24. pii: S0001-2998(22)00039.
    PubMed     Abstract available


  23. HILDEBRANDT MG, Naghavi-Behzad M, Vogsen M
    A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
    Semin Nucl Med. 2022 May 4. pii: S0001-2998(22)00029.
    PubMed     Abstract available


  24. HANSEN SB, Bender D
    Advancement in Production of Radiotracers.
    Semin Nucl Med. 2022;52:266-275.
    PubMed     Abstract available


    March 2022
  25. PARK EA, Graves SA, Menda Y
    The Impact of Radiopharmaceutical Therapy on Renal Function.
    Semin Nucl Med. 2022 Mar 18. pii: S0001-2998(22)00018.
    PubMed     Abstract available


  26. ADLER SS, Seidel J, Choyke PL
    Advances in Preclinical PET.
    Semin Nucl Med. 2022 Mar 17. pii: S0001-2998(22)00016.
    PubMed     Abstract available


  27. NG QK, Triumbari EKA, Omidvari N, Cherry SR, et al
    Total-body PET/CT - first clinical experiences and future perspectives.
    Semin Nucl Med. 2022 Mar 7. pii: S0001-2998(22)00002.
    PubMed     Abstract available


  28. BRUCKMANN NM, Morawitz J, Fendler WP, Ruckhaberle E, et al
    A Role of PET/MR in Breast Cancer?
    Semin Nucl Med. 2022 Mar 5. pii: S0001-2998(22)00003.
    PubMed     Abstract available


  29. POLOMSKI ES, Antoni ML, Jukema JW, Kroep JR, et al
    Nuclear medicine imaging methods of radiation-induced cardiotoxicity.
    Semin Nucl Med. 2022 Mar 1. pii: S0001-2998(22)00013.
    PubMed     Abstract available


    February 2022
  30. RITT P
    Recent Developments in SPECT/CT.
    Semin Nucl Med. 2022 Feb 21. pii: S0001-2998(22)00004.
    PubMed     Abstract available


    January 2022
  31. ZANOTTI-FREGONARA P
    Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals.
    Semin Nucl Med. 2022 Jan 21. pii: S0001-2998(21)00108.
    PubMed     Abstract available


  32. WERNER RA, Pomper MG, Buck AK, Rowe SP, et al
    SPECT and PET Radiotracers in Renal Imaging.
    Semin Nucl Med. 2022 Jan 17. pii: S0001-2998(21)00104.
    PubMed     Abstract available


  33. MENA E, Lindenberg L, Choyke P
    The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment.
    Semin Nucl Med. 2022 Jan 8. pii: S0001-2998(21)00109.
    PubMed     Abstract available


  34. BOUCHELOUCHE K
    PET/CT in Bladder Cancer: An Update.
    Semin Nucl Med. 2022 Jan 4. pii: S0001-2998(21)00105.
    PubMed     Abstract available


  35. ZUCKIER LS
    Safe Pulmonary Scintigraphy in the Era of COVID-19.
    Semin Nucl Med. 2022;52:48-55.
    PubMed     Abstract available


    December 2021
  36. SEIFERT R, Kersting D, Rischpler C, Opitz M, et al
    Clinical Use of PET/MR in Oncology: An Update.
    Semin Nucl Med. 2021 Dec 31. pii: S0001-2998(21)00099.
    PubMed     Abstract available


  37. BOGDANOVIC B, Solari EL, Villagran Asiares A, McIntosh L, et al
    PET/MR Technology: Advancement and Challenges.
    Semin Nucl Med. 2021 Dec 27. pii: S0001-2998(21)00101.
    PubMed     Abstract available


  38. MARENGO M, Martin CJ, Rubow S, Sera T, et al
    Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine.
    Semin Nucl Med. 2021 Dec 13. pii: S0001-2998(21)00093.
    PubMed     Abstract available


  39. TREVES ST, Fahey FH
    Radiation Dose to Pediatric Patients From Radiopharmaceuticals.
    Semin Nucl Med. 2021 Dec 13. pii: S0001-2998(21)00094.
    PubMed     Abstract available


  40. KENNEDY J, Chicheportiche A, Keidar Z
    Quantitative SPECT/CT for dosimetry of peptide receptor radionuclide therapy.
    Semin Nucl Med. 2021 Dec 12. pii: S0001-2998(21)00091.
    PubMed     Abstract available


  41. INOUE Y
    Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography.
    Semin Nucl Med. 2021 Dec 6. pii: S0001-2998(21)00096.
    PubMed     Abstract available


  42. FARINA A, Gasperini C, Aparisi Gomez MP, Bazzocchi A, et al
    The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
    Semin Nucl Med. 2021 Dec 6. pii: S0001-2998(21)00076.
    PubMed     Abstract available


  43. VINNIKOV V, Belyakov O
    Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures.
    Semin Nucl Med. 2021 Dec 6. pii: S0001-2998(21)00095.
    PubMed     Abstract available


    November 2021
  44. LOPEZ-MORA DA, Carrio I, Flotats A
    Digital PET vs Analog PET: Clinical Implications?
    Semin Nucl Med. 2021 Nov 23. pii: S0001-2998(21)00080.
    PubMed     Abstract available


  45. AIDE N, Lasnon C, Desmonts C, Armstrong IS, et al
    Advances in PET-CT technology: An update.
    Semin Nucl Med. 2021 Nov 22. pii: S0001-2998(21)00081.
    PubMed     Abstract available


  46. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
    Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use.
    Semin Nucl Med. 2021 Nov 19. pii: S0001-2998(21)00077.
    PubMed     Abstract available


    July 2021
  47. PILKINGTON P, Lopci E, Adam JA, Kobe C, et al
    FDG-PET/CT Variants and Pitfalls in Haematological Malignancies.
    Semin Nucl Med. 2021 Jul 13. pii: S0001-2998(21)00046.
    PubMed     Abstract available


  48. MEI R, Farolfi A, Castellucci P, Nanni C, et al
    PET/CT variants and pitfalls in prostate cancer: What you might see on PET and should never forget.
    Semin Nucl Med. 2021 Jul 12. pii: S0001-2998(21)00048.
    PubMed     Abstract available


  49. DEJANOVIC D, Hansen NL, Loft A
    PET/CT Variants and Pitfalls in Gynecological Cancers.
    Semin Nucl Med. 2021 Jul 9. pii: S0001-2998(21)00038.
    PubMed     Abstract available


  50. VAN DE WIELE C, Juanito G, Vander BK, Ismaheel L, et al
    Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients.
    Semin Nucl Med. 2021 Jul 7. pii: S0001-2998(21)00042.
    PubMed     Abstract available


  51. PIJL JP, Nienhuis PH, Kwee TC, Glaudemans AWJM, et al
    Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.
    Semin Nucl Med. 2021 Jul 7. pii: S0001-2998(21)00040.
    PubMed     Abstract available


  52. TSAI YJ, Liu C
    Pitfalls on PET/CT Due to Artifacts and Instrumentation.
    Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00047.
    PubMed     Abstract available


  53. VASIREDDI A, Nguyen NC
    PET/CT limitations and pitfalls in urogenital cancers.
    Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00045.
    PubMed     Abstract available


  54. AGRAWAL A, Shah S, Gnanasegaran G, Rajkotia S, et al
    PET/CT Normal Variants and Pitfalls in Pediatric disorders.
    Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00039.
    PubMed     Abstract available


  55. BENZ MR, Crompton JG, Harder D
    PET/CT variants and pitfalls in bone and soft tissue sarcoma.
    Semin Nucl Med. 2021 Jul 5. pii: S0001-2998(21)00041.
    PubMed     Abstract available


  56. KIRIENKO M, Telo S, Hustinx R, Bomanji JB, et al
    The Impact of COVID-19 on Nuclear Medicine in Europe.
    Semin Nucl Med. 2021 Jul 1. pii: S0001-2998(21)00054.
    PubMed     Abstract available


  57. VOLKAN-SALANCI B, Erbas B
    Imaging in Renal Transplants: An Update.
    Semin Nucl Med. 2021;51:364-379.
    PubMed     Abstract available


  58. CLEMMENSEN TS, Jensen NM, Eiskjaer H
    Imaging of Cardiac Transplantation: An Overview.
    Semin Nucl Med. 2021;51:335-348.
    PubMed     Abstract available


  59. CHEN W, Dilsizian V
    Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections.
    Semin Nucl Med. 2021;51:357-363.
    PubMed     Abstract available


    June 2021
  60. MILLS RA, Thompson RC
    Cardiac PET and SPECT During the COVID-19 Pandemic.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00052.
    PubMed     Abstract available


  61. EIBSCHUTZ LS, Rabiee B, Asadollahi S, Gupta A, et al
    FDG-PET/CT of COVID-19 and Other Lung Infections.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00049.
    PubMed     Abstract available


  62. GIAMMARILE F, Delgado Bolton RC, El-Haj N, Mikhail M, et al
    Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00050.
    PubMed     Abstract available


  63. PAEZ D, Mikhail-Lette M, Gnanasegaran G, Dondi M, et al
    Nuclear Medicine Departments in the Era of COVID-19.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00051.
    PubMed     Abstract available


  64. ANTONIOS L, Chen W, Dilsizian V
    The Impact of COVID-19 on Nuclear Medicine Operations Including Cardiovascular Manifestations in the USA.
    Semin Nucl Med. 2021 Jun 17. pii: S0001-2998(21)00035.
    PubMed     Abstract available


  65. ZAMORA E, Moadel RM, Song N, Zuckier LS, et al
    Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19.
    Semin Nucl Med. 2021 Jun 17. pii: S0001-2998(21)00037.
    PubMed     Abstract available


  66. BOM HH, Pascual TN, Choudhury PS, Al-Ibraheem A, et al
    Impact of COVID-19 on Nuclear Medicine in Asia.
    Semin Nucl Med. 2021 Jun 16. pii: S0001-2998(21)00033.
    PubMed     Abstract available


  67. KIKANO EG, Avril S, Marshall H, Jones RS, et al
    PET/CT Variants and Pitfalls in Breast Cancers.
    Semin Nucl Med. 2021 Jun 1. pii: S0001-2998(21)00021.
    PubMed     Abstract available


    May 2021
  68. ARSLAN E, Cermik TF
    PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas.
    Semin Nucl Med. 2021 May 25. pii: S0001-2998(21)00022.
    PubMed     Abstract available


  69. SINGH V, Dorbala S
    Normal Variants and Pitfalls in Cardiac PET/CT.
    Semin Nucl Med. 2021 May 25. pii: S0001-2998(21)00020.
    PubMed     Abstract available


  70. AFAQ A, Faul D, Chebrolu VV, Wan S, et al
    Pitfalls on PET/MRI.
    Semin Nucl Med. 2021 May 18. pii: S0001-2998(21)00019.
    PubMed     Abstract available


  71. LOPCI E, Kobe C, Gnanasegaran G, Adam JA, et al
    "PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma".
    Semin Nucl Med. 2021 May 11. pii: S0001-2998(21)00018.
    PubMed     Abstract available


  72. JAYAPRAKASAM VS, Paroder V, Schoder H
    Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.
    Semin Nucl Med. 2021 May 5. pii: S0001-2998(21)00017.
    PubMed     Abstract available


  73. MIHAILOVIC J, Killeen RP, Duignan JA
    PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer.
    Semin Nucl Med. 2021 May 1. pii: S0001-2998(21)00015.
    PubMed     Abstract available


  74. KRISHNADAS N, Villemagne VL, Dore V, Rowe CC, et al
    Advances in Brain Amyloid Imaging.
    Semin Nucl Med. 2021;51:241-252.
    PubMed     Abstract available


  75. BEYER L, Brendel M
    Imaging of Tau Pathology in Neurodegenerative Diseases: An Update.
    Semin Nucl Med. 2021;51:253-263.
    PubMed     Abstract available


  76. FRANTELLIZZI V, Conte M, De Vincentis G
    Hybrid Imaging of Vascular Cognitive Impairment.
    Semin Nucl Med. 2021;51:286-295.
    PubMed     Abstract available


    April 2021
  77. IMPERIALE A, Meuter L, Pacak K, Taieb D, et al
    Variants and Pitfalls of PET/CT in Neuroendocrine Tumors.
    Semin Nucl Med. 2021 Apr 7. pii: S0001-2998(21)00014.
    PubMed     Abstract available


  78. CECCHIN D, Garibotto V, Law I, Goffin K, et al
    PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls.
    Semin Nucl Med. 2021 Apr 3. pii: S0001-2998(21)00016.
    PubMed     Abstract available


    January 2021
  79. JENSEN K, Al-Farra G, Dejanovic D, Eriksen JG, et al
    Imaging for Target Delineation in Head and Neck Cancer Radiotherapy.
    Semin Nucl Med. 2021;51:59-67.
    PubMed     Abstract available


  80. SKANJETI A, Dhomps A, Paschetta C, Tordo J, et al
    Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer.
    Semin Nucl Med. 2021;51:39-49.
    PubMed     Abstract available


  81. JUNN JC, Soderlund KA, Glastonbury CM
    Imaging of Head and Neck Cancer With CT, MRI, and US.
    Semin Nucl Med. 2021;51:3-12.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: